John A. Sedor
2016
In 2016, John A. Sedor earned a total compensation of $1.9M as Chief Executive Officer at Pernix Therapeutics Holdings.
Compensation breakdown
| Bonus | $411,762 |
|---|---|
| Non-Equity Incentive Plan | $125,000 |
| Option Awards | $505,195 |
| Salary | $393,972 |
| Stock Awards | $440,496 |
| Other | $51,412 |
| Total | $1,927,837 |
Sedor received $505.2K in option awards, accounting for 26% of the total pay in 2016.
Sedor also received $411.8K in bonus, $125K in non-equity incentive plan, $394K in salary, $440.5K in stock awards and $51.4K in other compensation.
Rankings
In 2016, John A. Sedor's compensation ranked 5,045th out of 14,075 executives tracked by ExecPay. In other words, Sedor earned more than 64.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,045 out of 14,075 | 64th |
Division Manufacturing | 1,800 out of 5,486 | 67th |
Major group Chemicals And Allied Products | 571 out of 1,900 | 70th |
Industry group Drugs | 427 out of 1,543 | 72nd |
Industry Pharmaceutical Preparations | 342 out of 1,173 | 71st |
Source: SEC filing on April 9, 2018.
Sedor's colleagues
We found one more compensation record of an executive who worked with John A. Sedor at Pernix Therapeutics Holdings in 2016.
2016
Graham Miao
Pernix Therapeutics Holdings